Viewing Study NCT02639650


Ignite Creation Date: 2025-12-24 @ 5:17 PM
Ignite Modification Date: 2026-01-04 @ 5:49 PM
Study NCT ID: NCT02639650
Status: RECRUITING
Last Update Posted: 2022-06-03
First Post: 2015-12-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor
Sponsor: Weiguo Lv
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module